A Single-Centered Cohort Study on Favipiravir Safety and Efficacy in Pediatric Patients with COVID-19.
Sedigheh Rafiei TabatabaeiOmid MoradiAbdollah KarimiShahnaz ArminAlireza FahimzadRoxana Mansour GhanaieMahnaz JameeAzam MousavizadehHossein AminiBahador MirrahimiPublished in: Iranian journal of pharmaceutical research : IJPR (2022)
The administration of favipiravir in the pediatric population is associated with higher ADR occurrence with no positive effect on the need for invasive mechanical ventilation, hospital stay, and mortality. Further randomized controlled trials are necessary for better judgment.
Keyphrases
- mechanical ventilation
- acute respiratory distress syndrome
- intensive care unit
- adverse drug
- randomized controlled trial
- respiratory failure
- risk assessment
- healthcare
- cardiovascular events
- risk factors
- extracorporeal membrane oxygenation
- cardiovascular disease
- clinical trial
- coronary artery disease
- systematic review
- young adults
- study protocol
- meta analyses